Module Contents Main homework exercises No. of pages 1 Introduction and information about social anxiety and the treatment Reading text about social anxiety, answering questions to show that one understands…
1. Symptoms Dissatisfaction with sleep quantity or quality and one (or more) of the following symptoms: (a) Difficulty initiating sleep (b) Difficulty maintaining sleep (frequent awakenings or problems returning to…
Study ID Country Participants Type N Exp. groups Follow-up Lange 2000 NL Traumatised students Pilot 20 oSWT 6 weeks Lange 2001 NL Traumatised students RCT 30 oSWT vs. WLC 18…
Program and country of origin Duration and number of modules/lessons Main contents Mode of presentation Reference example supporting use Relapse prevention program (ISIDOR) Sweden 10 weeks 9 basic modules and…
Educational material Applied relaxation or other relaxation/de-arousal intervention Cognitive restructuring for thoughts, beliefs and meta-cognitive beliefs Scheduled worry time Problem solving Worry exposure/behavioural experiments Interpersonal problem solving and/or communication…
© Springer International Publishing Switzerland 2016Nils Lindefors and Gerhard Andersson (eds.)Guided Internet-Based Treatments in Psychiatry10.1007/978-3-319-06083-5_1 1. History and Current Status of ICBT Gerhard Andersson1, 2 , Per Carlbring3 and Nils Lindefors4 (1) Department of Behavioural Sciences and Learning, Linköping…
© Springer International Publishing Switzerland 2016Janusz K. Rybakowski and Alessandro Serretti (eds.)Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders10.1007/978-3-319-27040-1_7 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant, and Mood-Stabilizing Drugs Alessandro Serretti1 and…
Pharmacodynamic profile Pharmacokinetic profile Haloperidol D2, D3, D4 CYP2D6, CYP3A4 Chlorpromazine D2, D3, D4, 5-HT2A, 5-HT2C, 5-HT6 CYP2D6, CYP1A2 Clozapine 5-HT2A, 5-HT2C, 5-HT6, D4, D2, H1, M1, ADR1A CYP1A2,…
Mood stabilizer Neurobiology area Positive findings Authors Lithium Neurotransmission 5–HTT gene TPH gene DRD1 gene FYN gene Serretti et al. [72, 74], Rybakowski et al. [59], Tharoor et al. [87]…
Gene Polymorphism Main findings CYP1A2 (*1F, −163C>А, rs762551) CC genotype and/or C allele are possible risk factors for tardive dyskinesia SLC18A2 rs2015586 C allele can be a risk variant for…
